HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides

Mathieu, M.G., Knights, A.J., Pawelec, G., Riley, C.L., Wernet, D., Lemonnier, F.A., Straten, P.T., Mueller, L., Rees, R.C. ORCID: 0000-0002-4574-4746 and McArdle, S.E. ORCID: 0000-0001-6929-9782, 2007. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy, 56 (12), pp. 1885-1895. ISSN 0340-7004

Full text not available from this repository.
Item Type: Journal article
Publication Title: Cancer Immunology Immunotherapy
Creators: Mathieu, M.G., Knights, A.J., Pawelec, G., Riley, C.L., Wernet, D., Lemonnier, F.A., Straten, P.T., Mueller, L., Rees, R.C. and McArdle, S.E.
Date: 2007
Volume: 56
Number: 12
ISSN: 0340-7004
Divisions: Schools > School of Science and Technology
Record created by: EPrints Services
Date Added: 09 Oct 2015 10:27
Last Modified: 24 Nov 2021 14:23
URI: http://irep.ntu.ac.uk/id/eprint/13151

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year